Clinical TrialsSearch results
Number of results: 284
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Tadalafil for fetus with early-onset growth restriction (TADAFER IIb)
- Fetal growth restriction
- Takakura Sho
- 2019-09-02
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-II: Multicenter phase II clinical trial for children with non-T-ALL in intermediate risk group stratified by the minimal residual disease (MRD).
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-06-01
Other
- Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study
- first relapsed acute lymphoblastic leukemia in children
- Japanese Peditric Leukemia/Lymphoma Study Group
- 2009-06-01
Other
- Efficacy and safety of first-line Vinorelbine single agent in patints with refractory to anthracycline and taxane
- First-line metastatic breast cancer
- Department of Breast and Endocrine surgery, Nagoya University school of medicine
- 2007-01-10
Other
- A phase III study of RO7030816(mosunetuzumab) in patients with follicular lymphoma after at least one line of systemic therapy
- FOLLICULAR LYMPHOMA AFTER AT LEAST ONE LINE OF SYSTEMIC THERAPY
- Enkhee Purev
- 2021-08-06
Other
- Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer
- gallbladder cancer
- Nagoya University Hospital
- 2008-07-25
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01